Anti-APP (Crenezumab)-MC-MMAF ADC
This ADC product is comprised of an anti-APP monoclonal antibody conjugated via a MC linker to MMAF. The MMAF is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
Product Specifications
CAS Number
9007-83-4
Format
Solution
Shipping Conditions
Ice Packs
Storage Conditions
-20°C
More Discoveries
Explore Other Products
Browse additional items from our catalog
330600-01 50 µg
SMARCA2 (Probable global Transcription Activator SNF2L2, ATP-Dependent Helicase SMARCA2, BRG1-Associated Factor 190B, BAF190B, Protein brahma Homolog, hBRM, SNF2-alpha, SNF2-alpha, SNF2alpha, SWI/SNF-Related Matrix-Associated Actin-Dependent Regulator of chromatin Subfamily A Member 2, BRM, BAF190B, SNF2A, SNF2L2) (FITC)
Sign In for Pricing
View Details 
330600-02 100 µg
SMARCA2 (Probable global Transcription Activator SNF2L2, ATP-Dependent Helicase SMARCA2, BRG1-Associated Factor 190B, BAF190B, Protein brahma Homolog, hBRM, SNF2-alpha, SNF2-alpha, SNF2alpha, SWI/SNF-Related Matrix-Associated Actin-Dependent Regulator of chromatin Subfamily A Member 2, BRM, BAF190B, SNF2A, SNF2L2) (FITC)
Sign In for Pricing
View Details NBP2-34529MFV450 0.1 mL
Mouse Monoclonal ACTH Antibody (2F6) [mFluor Violet 450 SE]
Sign In for Pricing
View Details 